Reynier, Pascal

OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes

Amati-Bonneau, P., Valentino, M. L., Reynier, P., Gallardo, M. E., Bornstein, B., Boissiere, A., Campos, Y., Rivera, H., de la Aleja, J. G., Carroccia, R., et al. (2008) · Brain

Mitochondrial Function and PathologyHereditary Neurological Disorders

Cited by 520

Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance

Hudson, G., Amati-Bonneau, P., Blakely, E. L., Stewart, J. D., He, L., Schaefer, A. M., Griffiths, P. G., Ahlqvist, K., Suomalainen, A., Reynier, P., et al. (2008) · Brain

Mitochondrial Function and PathologyHereditary Neurological Disorders

Cited by 428

Low serum testosterone assayed by liquid chromatography-tandem mass spectrometry. Comparison with five immunoassay techniques

Moal, V., Mathieu, E., Reynier, P., Malthièry, Y., & Gallois, Y. (2007) · Clinica Chimica Acta

Hormonal and reproductive studiesClinical Laboratory Practices and Quality Control

Cited by 154

Serum ferritin/C-reactive protein ratio is a simple and effective biomarker for diagnosing iron deficiency in the context of systemic inflammation

Urbanski, G., Chabrun, F., Lavigne, C., Lacout, C., Delattre, E., Reynier, P., & Requin, J. (2024) · QJM: An International Journal of Medicine

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 12

Apparent resistance to thyroid hormones: From biological interference to genetics

Dieu, X., Sueur, G., Moal, V., Boux de Casson, F., Bouzamondo, N., Bouhours, N., Briet, C., Illouz, F., Reynier, P., Coutant, R., et al. (2019) · Annales d'Endocrinologie

Thyroid Disorders and TreatmentsGenomics and Rare Diseases

Cited by 12